1
|
DeSantis CE, Ma J, Goding Sauer A, Newman
LA and Jemal A: Breast cancer statistics, 2017, racial disparity in
mortality by state. CA Cancer J Clin. 67:439–448. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Nowbar AN, Howard JP, Finegold JA, Asaria
P and Francis DP: 2014 global geographic analysis of mortality from
ischaemic heart disease by country, age and income: Statistics from
world health organisation and united nations. Int J Cardiol.
174:293–298. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Stewart BW and Wild CP: The global and
regional burden of cancerWorld Cancer Report 2014. World Health
Organization; Geneva: pp. 162014
|
4
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 Cancer Incidence and Mortality Worldwide:
IARC CancerBase No. 11 [Internet]. v1.0. International Agency for
Research on Cancer; Lyon, France: 2013 Decembet 12–2016
|
5
|
Kosir MA: Breast Cancer. MSD manual
consumer version. https://www.msdmanuals.com/home/women-s-health-issues/breast-disorders/breast-cancer%C2%A0Decembet
12–2016
|
6
|
Reeder JG and Vogel VG: Breast cancer
prevention. Cancer Treatment and Res. 141:149–164. 2008. View Article : Google Scholar
|
7
|
Gage M, Wattendorf D and Henry LR:
Translational advances regarding hereditary breast cancer
syndromes. J Surg Oncol. 105:444–451. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Colditz GA, Kaphingst KA, Hankinson SE and
Rosner B: Family history and risk of breast cancer: Nurses' health
study. Breast Cancer Res Treat. 133:1097–1104. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Dalmay T: Mechanism of miRNA-mediated
repression of mRNA translation. Essays Biochem. 54:29–38. 2013.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang C, Xie SH, Xu B, Lu S and Liu P:
Digitalis use and the risk of breast cancer: A systematic review
and meta-analysis. Drug Saf. 40:285–292. 2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids
Res. 36:D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kozomara A and Griffiths-Jones S: miRBase:
Integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39:152–157. 2011. View Article : Google Scholar
|
16
|
Lewis BP, Shih Ih, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Dennis G, Sherman BT, Hosack DA, Yang J,
Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. Nat
Genet. 25:25–29. 2000. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Kanehisa M, Goto S, Kawashima S, Okuno Y
and Hattori M: The KEGG resource for deciphering the genome.
Nucleic Acids Res. 32:D277–D280. 2004. View Article : Google Scholar : PubMed/NCBI
|
21
|
Essaghir A, Toffalini F, Knoops L, Kallin
A, van Helden J and Demoulin JB: Transcription factor regulation
can be accurately predicted from the presence of target gene
signatures in microarray gene expression data. Nucleic Acids Res.
38:e1202010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Essaghir A and Demoulin JB: A minimal
connected network of transcription factors regulated in human
tumors and its application to the quest for universal cancer
biomarkers. PLoS One. 7:e396662012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Shimono Y, Zabala M, Cho RW, Lobo N,
Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, et al:
Downregulation of miRNA-200c links breast cancer stem cells with
normal stem cells. Cell. 138:592–603. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:pp. 2257–2261.
2006; View Article : Google Scholar : PubMed/NCBI
|
25
|
Heneghan HM, Miller N, Lowery AJ, Sweeney
KJ, Newell J and Kerin MJ: Circulating microRNAs as novel minimally
invasive biomarkers for breast cancer. Ann Surg. 251:499–505. 2010.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Lowery AJ, Miller N, McNeill RE and Kerin
MJ: MicroRNAs as prognostic indicators and therapeutic targets:
Potential effect on breast cancer management. Clin Cancer Res.
14:360–365. 2008. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kastl L, Brown I and Schofield AC:
miRNA-34a is associated with docetaxel resistance in human breast
cancer cells. Breast Cancer Res Treat. 131:445–454. 2012.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H
and Hu C: Circulating microRNA-92a and microRNA-21 as novel
minimally invasive biomarkers for primary breast cancer. J Cancer
Res Clin Oncol. 139:223–229. 2013. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
31
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
32
|
Kong W, He L, Richards EJ, Challa S, Xu
CX, Permuth-Wey J, Lancaster JM, Coppola D, Sellers TA, Djeu JY and
Cheng JQ: Upregulation of miRNA-155 promotes tumour angiogenesis by
targeting VHL and is associated with poor prognosis and
triple-negative breast cancer. Oncogene. 33:679–689. 2014.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Jiang H, Zhang G, Wu JH and Jiang CP:
Diverse roles of miR-29 in cancer (review). Oncol Rep.
31:1509–1516. 2014. View Article : Google Scholar : PubMed/NCBI
|
34
|
Michael MZ, O'Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific MicroRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
35
|
Sun YM, Lin KY and Chen YQ: Diverse
functions of miR-125 family in different cell contexts. J Hematol
Oncol. 6:62013. View Article : Google Scholar : PubMed/NCBI
|
36
|
Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo
Z, Dong W, Huang J and Lin T: MicroRNA-125b suppresses the
development of bladder cancer by targeting E2F3. Int J Cancer.
128:1758–1769. 2011. View Article : Google Scholar : PubMed/NCBI
|
37
|
Cowden Dahl KD, Dahl R, Kruichak JN and
Hudson LG: The epidermal growth factor receptor responsive miR-125a
represses mesenchymal morphology in ovarian cancer cells.
Neoplasia. 11:1208–1215. 2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Rajabi H, Jin C, Ahmad R, McClary AC,
Joshi MD and Kufe D: Mucin 1 oncoprotein expression is suppressed
by the miR-125b oncomir. Genes Cancer. 1:62–68. 2010. View Article : Google Scholar : PubMed/NCBI
|
39
|
Kaenel P, Mosimann M and Andres AC: The
multifaceted roles of Eph/ephrin signaling in breast cancer. Cell
Adh Migr. 6:138–147. 2012. View Article : Google Scholar : PubMed/NCBI
|
40
|
Harburg GC and Hinck L: Navigating breast
cancer: Axon guidance molecules as breast cancer tumor suppressors
and oncogenes. J Mammary Gland Biol Neoplasia. 16:257–270. 2011.
View Article : Google Scholar : PubMed/NCBI
|